Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 11096028.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Parainfluenza virus (PIV) infection can be a problem among hematopoetic stem cell transplant recipients. 125 patients were prospectively evaluated for respiratory viral infections. We describe 5 patients with PIV 3 infection and their response to early treatment with ribavirin.
Medical subject headings
- Antiviral Agents
- Hematopoietic Stem Cell Transplantation
- Parainfluenza Virus 3, Human
- Respiratory Tract Infections
- Respirovirus Infections
- Ribavirin